Michael Thornton's most recent trade in ENDRA Life Sciences Inc was a trade of 15,000 Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on May 18, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ENDRA Life Sciences Inc | Michael Thornton | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 1.65 per share. | 18 May 2023 | 15,000 | 34,139 | - | 1.7 | 24,750 | Common Stock |
| ENDRA Life Sciences Inc | Michael Thornton | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 68,066 | 68,066 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Michael Thornton | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 3.40 per share. | 09 Dec 2022 | 1,500 | 19,139 | - | 3.4 | 5,100 | Common Stock |
| ENDRA Life Sciences Inc | Michael Thornton | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 0.27 per share. | 22 Aug 2022 | 20,000 | 352,775 | - | 0.3 | 5,400 | Common Stock |
| ENDRA Life Sciences Inc | Michael Thornton | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 0.21 per share. | 26 May 2022 | 25,000 | 332,775 | - | 0.2 | 5,250 | Common Stock |
| ENDRA Life Sciences Inc | Michael Thornton | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 0.22 per share. | 18 May 2022 | 25,000 | 307,775 | - | 0.2 | 5,500 | Common Stock |
| ENDRA Life Sciences Inc | Michael Thornton | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 698,102 | 698,102 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Michael Thornton | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2021 | 50,000 | 50,000 | - | - | Stock Options | |
| ENDRA Life Sciences Inc | Michael Thornton | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.37 per share. | 29 Mar 2021 | 18,750 | 274,960 | - | 2.4 | 44,438 | Common Stock |
| ENDRA Life Sciences Inc | Michael Thornton | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.53 per share. | 29 Mar 2021 | 15,000 | 259,960 | - | 2.5 | 37,950 | Common Stock |
| ENDRA Life Sciences Inc | Michael Thornton | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 22,815 | 316,525 | - | 0 | Common Stock | |
| ENDRA Life Sciences Inc | Michael Thornton | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 22,815 | 316,525 | - | 0 | Common Stock |